Hemo Organic Limited has cancelled its board of directors meeting scheduled for September 23, 2026. The company cited unavoidable reasons for the cancellation in an intimation to BSE Limited dated September 21, 2026.

The cancelled meeting was originally convened to consider proposals for raising funds through various permissible modes, including qualified institutions placement (QIP) and preferential allotment. The board had planned to approve the issuance of equity shares or convertible securities.

Previous Agenda Details

The earlier agenda included considering the issuance of equity shares and convertible securities, including convertible warrants. The company was exploring options to raise funds in one or more tranches through:

• Preferential allotment
• Private placement
• Qualified institutions placement (QIP)
• Rights issue
• Further public issue

These actions required statutory approvals and consent from members. The board was also set to consider any ancillary actions required for such fund raising.

Regulatory Compliance

The initial disclosure regarding the meeting was made pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Ayush Dharmendrabhai Jasani, Chairman and Additional Director, signed the intimation letter addressed to BSE Limited.

In compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window had been closed starting from business closing hours on September 19, 2026. This restriction continues until 48 hours after the conclusion of the board meeting, although the meeting itself is now cancelled.

Hemo Organic Limited has accepted the resignation of Yukta Prakash Patel from her role as Company Secretary and Compliance Officer. The departure becomes effective immediately following the closure of business hours on September 19, 2026.

The company disclosed the change to BSE Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing references SEBI Circular No. SEBI/ HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, regarding detailed disclosures for such changes.

Resignation Details

Yukta Prakash Patel, who holds ICSI Membership No. A76482, tendered her resignation citing personal reasons. She confirmed in her resignation letter that there are no other material reasons for her departure beyond those stated.

The Board of Directors accepted the resignation on the same date. Vishwambar Kameshwar Singh, Managing Director, authorized the disclosure on behalf of the company. The firm will proceed with filing the necessary forms with the Ministry of Corporate Affairs.